Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Selective Targeting of CTNNB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs

  • The PLOS ONE Staff
  • Article
  • Metrics
  • Comments
  • Media Coverage

Notice of Republication

This article was republished on June 15, 2015, to correct an error in the title. The publisher apologizes for the error. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected article are provided here for reference.

Supporting Information

S1 File. Originally published, uncorrected article.

https://doi.org/10.1371/journal.pone.0132230.s001

(PDF)

S2 File. Republished, corrected article.

https://doi.org/10.1371/journal.pone.0132230.s002

(PDF)

Reference

  1. 1. Uitdehaag JCM, de Roos JADM, van Doornmalen AM, Prinsen MBW, Spijkers-Hagelstein JAP, de Vetter JRF, et al. (2015) Selective Targeting of CTNNB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs. PLoS ONE 10(5): e0125021. pmid:26018524

Citation: The PLOS ONE Staff (2015) Correction: Selective Targeting of CTNNB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs. PLoS ONE 10(6): e0132230. https://doi.org/10.1371/journal.pone.0132230

Published: June 29, 2015

Copyright: © 2015 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited